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ttp://dx.doi.org/10.1016/j.ajpath.2013.05.008In response to tissue injuries, terminally differentiated cells are reprogrammed to undergo dedifferen-
tiation to gain mitogenic and metabolic properties. The dedifferentiated cells acquire an immature
phenotype, proliferate actively, produce abundant extracellular matrix, and recruit circulating leukocytes
via secretion of chemokines, contributing to tissue repair and/or ﬁbrosis. However, this remodeling
process is self-limiting, and in the later phase, the activated, dedifferentiated cells are reprogrammed to
redifferentiate into a mature, quiescent phenotype. Currently, molecular mechanisms underlying this
bidirectional pathological reprogramming remain elusive. It is known that the unfolded protein response
(UPR) is induced at local tissues under pathological situations and affects cellular fatedsurvival or death.
It is also known that the UPR is involved in cell differentiation and organogenesis during embryonic
development. In this review, we describe a hypothesis for regulatory roles of the UPR in the pathological
reprogramming of somatic cells (ie, cellular dedifferentiation and redifferentiation at the sites of injury).
(Am J Pathol 2013, 183: 644e654; http://dx.doi.org/10.1016/j.ajpath.2013.05.008)Supported by Grants-in-Aid for Scientiﬁc Research 20390235 from the
Ministry of Education, Culture, Sports, Science and Technology, Japan
(M.K.).The response to injury is a dynamic and complex process and
involves a series of coordinated events, including leukocyte
inﬁltration, resident cell proliferation, and accumulation
of extracellular matrix (ECM). If this process progresses
appropriately, normal tissues are reconstructed. However, the
repair process is disturbed by various local factors, including
infection, hypoxia, and excess levels of inﬂammatory cyto-
kines, resulting in abnormal repair, such as ﬁbrosis.
In the response to injury, terminally differentiated local cells
are reprogrammed to undergo dedifferentiation or trans-
differentiation to gain active mitogenic and metabolic prop-
erties. One typical example is dedifferentiation of glomerular
mesangial cells. Under inﬂammatory conditions, these cells
acquire a myoﬁbroblastic phenotype and contribute not only
to normal tissue repair but also to the development of glo-
merulosclerosis.1 Another typical example is epithelial-
mesenchymal transition (EMT) in which resident epithelialstigative Pathology.
.cells gain a phenotype characteristic of ﬁbroblasts. EMT is
required during normal embryonic development and wound
healing but may also lead to transformation into malignant
cells and ﬁbrogenic myoﬁbroblasts.2 Transforming growth
factor (TGF)-b is a crucial factor that promotes EMT and
myoﬁbroblast formation, and its dysregulation is involved in
carcinogenesis and ﬁbrosis.2 The similar story has also been
proposed in endothelial-mesenchymal transition in which
endothelial cells gain a ﬁbroblastic phenotype.3 Once they are
dedifferentiated, the cells proliferate actively, produce abun-
dant ECM, and recruit leukocytes via secretion of chemokines,
contributing to tissue repair and ﬁbrosis. However, this re-
modeling process is usually transient, and in the later phase,
UPR and Pathological Reprogrammingactivated, dedifferentiated cells undergo redifferentiation into
a mature, quiescent phenotype. Currently, molecular mecha-
nisms underlying the pathological in situ reprogramming of
local cells remain elusive.
The endoplasmic reticulum (ER) is an intracellular com-
partment that provides a unique environment for appropriate
folding and maturation of newly synthesized proteins. A
number of pathophysiological conditions (eg, hypoxia,
nutrient deprivation, infection, alteration of redox state,
changes in calcium balance, failure of posttranslational
modiﬁcations and increased general protein synthesis) lead to
accumulation of unfolded proteins in the ER, so-called ER
stress.4 To alleviate ER stress, cells activate evolutionarily
conserved signaling cascades [ie, the unfolded protein
response (UPR)]. The UPR comprises three major signaling
pathways mediated by protein kinase-like ER kinase
(PERK), activating transcription factor 6 (ATF6), and
inositol-requiring enzyme 1 (IRE1).5 The UPR leads to
attenuation of ER stress and restoration of ER function via
general translational suppression, induction of ER chaper-
ones, and up-regulation of ER-associated degradation.
However, if the stress is beyond the folding capacity of the
ER, speciﬁc cell death programs (proapoptotic UPR) are
activated, leading to apoptotic cell death.6 Although the UPR
is primarily regarded as cellular defense machinery to cope
with protein-folding stress, it also serves a wide range of
pathophysiological processes, including lipid metabolism,
energy homeostasis, and inﬂammatory processes.7
The UPR inﬂuences cellular states of activation and
differentiation. For example, the UPR induces activation of
NF-kB and thereby triggers production of a wide range ofTable 1 Induction of Dedifferentiation by the UPR
Disease/experimental model Evidence for UPR
Chondrocyte
Osteoarthritis (human) Grp78 [, Bag-1 [
Chondrodysplasia (mouse; muCola1X-tg/ki) Grp78 [, Chop [, Xbp
Atf6 [
ER stress inducer (in vitro; TM, SNAP) Grp78 [, Chop [
ER stress inducer (in vitro; TG, TM, GW) Chop [, caspase-12 [
Alveolar epithelial cell
Idiopathic pulmonary ﬁbrosis (human) Chop [, Atf4 [, Atf6
Xbp1 [
Bleomycin-induced ﬁbrosis (mouse) Grp78 [
ER stress inducer (in vitro; TM, TG) Grp78 [, Xbp1 [
ER stress inducer (in vitro; TM, mSFTPC) Grp78 [, Edem [, eIF
Thyroid epithelial cell
ER stress inducer (in vitro; TM, TG) Grp78 [, Xbp1 [,
Perk/eIF2a [
a-SMA, a-smooth muscle actin; Atf6, activating transcription factor 6; Bag-1,
enhancing a-mannosidase-like protein; eIF2a, eukaryotic translation initiation fa
regulated protein; GW glucose withdrawal; mSFTPC, mutant surfactant protein C
sodium/iodide symporter; Perk, protein kinase-like ER kinase; SNAP, S-nitroso-N-ac
TTF, thyroid transcription factor; Xbp1, X-boxebinding protein 1; ZO-1, zonula o
The American Journal of Pathology - ajp.amjpathol.orginﬂammatory molecules, leading to initiation of inﬂamma-
tion.8 Accumulating evidence also suggests that the UPR is
involved in cell differentiation during embryogenesis. In the
embryonic and postembryonic organ development, the UPR
is physiologically activated in a variety of differentiating
cells. Analyses of gene-knockout mice revealed divergent
roles of the UPR in the development and maintenance of
various cell types.9 On the other hand, it is known that the
UPR is induced at local tissues under pathological situations.
The UPR may also be involved in the dedifferentiation and
redifferentiation of local cells during the process of tissue
repair and ﬁbrosis. In this article, we describe hypothetical
roles of the UPR in the pathological in situ reprogramming of
somatic cells toward dedifferentiation and redifferentiation.
Induction of Dedifferentiation by the UPR
Several previous reports indicated a role of the UPR in
dedifferentiation of terminally differentiated cells. In this
section, we describe effects of the UPR on the dedifferen-
tiation of some cell types, including chondrocytes, alveolar
epithelial cells, and thyroid epithelial cells (Table 1).
Chondrocytes
Bone elongation occurs at regions of specialized cartilage
(growth plate) situated at both ends of long bones. During
this process, chondrocytes originated from the resting zone
of the growth plate undergo a series of phenotypic changes,
including proliferating, prehypertrophic, and hypertrophic
phenotypes, before reaching a terminally differentiatedEvidence for dedifferentiation Reference
Aggrecan Y, collagen II Y 10,11
1 [, Prehypertrophic phenotype 12
Aggrecan Y, collagen II Y 13
Aggrecan Y, collagen II Y, link protein Y 14
[, EMT 15,16
EMT (histocytochemistry) 17,18
EMT (E-cadherin Y, ZO-1 Y, a-SMA [) 17
2a [ EMT (E-cadherin Y, ZO-1 Y, a-SMA [,
vimentin [, N-cadherin [, S100A4 [)
18
Thyroglobulin Y, TPO Y, NIS Y 19
TTF-1 Y, TTF-2 Y, Pax-8 Y
EMT (E-cadherin Y, vimentin [, a-SMA [,
collagen I [)
bcl-2eassociated athanogene 1; Edem, endoplasmic reticulum degradation
ctor 2a; EMT, epithelial-to-mesenchymal transition; Grp78, 78-kDa glucose-
; muCola1X-tg/ki, mutant collagen a1X-transgenic/knock-in mouse; NIS,
etylpenicillamine; TG, thapsigargin; TM, tunicamycin; TPO, thyroperoxidase;
ccludens-1.
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Johno and Kitamurastate.20 Chondrocytes are exposed to various stresses, such
as mechanical stress, hypoxic stress, and inﬂammatory
stress, all of which may affect the differentiation state of
chondroprogenitors and chondrocytes.21 Mature chondro-
cytes synthesize matrix proteins, including type II collagen,
aggrecan, and link protein (known markers for differentiated
chondrocytes). The steady-state levels of these cartilage
components are maintained by chondrocytes. However,
excessive stress leads chondrocytes to be unable to repair or
replace damaged areas of cartilage. Several reports indicated
a link between ER stress and chondrocyte dedifferentia-
tion.12,22 In patients with osteoarthritis, both the UPR and
cellular dedifferentiation are detectable in chondrocytes.10,11
Oliver et al13 reported that ER stress inducer tunicamycin
caused modest suppression of type II collagen and marked
inhibition of aggrecan expression in mature chondrocytes.
They also found that inﬂammatory cytokine IL-1b had the
similar effect, which was mediated by nitric oxideeinduced
ER stress. Yang et al14 found that ER stress triggered by
several different stimuli resulted in impaired accumulation
of Alcian Blueepositive ECM and type II collagen in
chondrocytes. They also found a down-regulation of ag-
grecan, type II collagen, and link protein mRNAs in ER
stresseexposed cells. Tsang et al12 studied an in vivo effect
of ER stress on terminally differentiating hypertrophic
chondrocytes during endochondral bone formation. They
generated transgenic mice expressing mutant type X collagen
that causes ER stress and found the following: i) ER stress is
induced in chondrocytes, ii) their terminal differentiation is
interrupted, and iii) endochondral bone formation is delayed,
producing a chondrodysplasia phenotype. This impaired
differentiation of chondrocytes involved cell-cycle reentry
and reexpression of genes characteristic of a prehypertrophic
phenotype of chondrocytes. Similarly, Rajpar et al22 gener-
ated knock-in mice that express mutant type X collagen. The
mutant mice exhibited short limbs and an expanded hyper-
trophic zone. The chondrocytes in the hypertrophic zone
exhibited a robust UPR and consequent disruption of nor-
mal gene expression. Taken together, these results raise two
possibilities. First, the UPR triggered by ER stress induces
dedifferentiation of hypertrophic chondrocytes toward im-
mature phenotypes. Second, the UPR may also disturb pre-
hypertrophic chondrocytes to differentiate into the mature,
hypertrophic phenotype.
Currently, it is not well understood how the UPR induces
dedifferentiation of chondrocytes, but Yu et al23 reported that
2-deoxy-D-glucose, an ER stress inducer, caused dediffer-
entiation of articular chondrocytes through the b-catenin
pathway. They found that this effect was ascribed to accu-
mulation of b-catenin via posttranslational modiﬁcation.
Another possibility is alteration in the TGF-b signaling. In
the maintenance of differentiated chondrocytes, the TGF-b
signal plays an important role.24 In age-related damage of
cartilage, dedifferentiation of chondrocytes is observed.
Some report provided evidence for down-regulation of
TGF-bs and TGF-b receptors in cartilage of old mice.25646Baugé et al24 reported that chondrocyte dedifferentiation
in vitro was associated with a decrease in the TGF-b type II
receptor level, and overexpression of the receptor in dedif-
ferentiated chondrocytes restored expression of aggrecan and
type II collagen. Similarly, Zhang et al26 reported that over-
expression of TGF-b3 facilitated redifferentiation of dedif-
ferentiated chondrocytes in vitro. As described later, ER
stress has the potential to affect TGF-b signaling either
positively or negatively. For example, in mesangial cells,
sustained ER stress suppresses TGF-b signaling via down-
regulation of Smads.27 Blockade of the TGF-b signaling
might cause dedifferentiation of chondrocytes by the UPR.
Alveolar Epithelial Cells
The pulmonary alveolar wall consists of three major cell
types: type I, squamous alveolar epithelial cells that form
the primary structure of an alveolar wall; type II, great alveolar
epithelial cells that secrete pulmonary surfactant; and type III,
macrophages that destroy foreign materials such as bacteria.
Previous investigations suggested a role of EMT in the path-
ogenesis of tissue ﬁbrosis, including lung ﬁbrosis.28 EMT
contributes to generation of the ﬁbroblast population in
pulmonary ﬁbrosis, and myoﬁbroblasts, the key effector cells,
have arisen from alveolar epithelial cells.29 In sporadic idio-
pathic pulmonary ﬁbrosis, ER stress and EMT are concur-
rently induced in type II alveolar cells.15,16 In vivo induction of
ER stress and EMT in type II alveolar cells is also reported in
bleomycin-induced pulmonary ﬁbrosis.17,18 Zhong et al17
have found that ER stress induced by thapsigargin or tunica-
mycin decreased expression of epithelial markers, E-cadherin,
and zonula occludens protein 1 (ZO-1), whereas induced
amyoﬁbroblast marker, a-smoothmuscle actin (a-SMA), and
ﬁbroblast-like morphology in type II alveolar epithelial cells.
Similar results were also reported by other investigators.
Tanjore et al30 found that treatment with tunicamycin induced
a ﬁbroblast-like appearance in alveolar epithelial cells. During
ER stress, expression of epithelial markers E-cadherin and
ZO-1 was depressed, whereas expression of mesenchymal
markers increased. They also found that after induction of ER
stress, activation of Smad andSrc pathwayswas observed, and
that combinational inhibition of Smad2/3 and Src kinase
blocked EMT, which was evidenced by maintenance of
epithelial appearance and epithelial marker expression. These
results suggest that the UPR induces EMT, a dedifferentiation
process, in lung epithelial cells and that the generated ﬁbro-
blasts contribute to pulmonary ﬁbrosis.
Thyroid Epithelial Cells
Thyroid epithelial cells (also called follicular cells or principal
cells) are cells in the thyroid gland responsible for the pro-
duction and secretion of thyroid hormones. Differentiation of
thyroid epithelial cells is accompanied by synthesis and se-
cretion of thyroglobulin, a thyroid hormone precursor, and
expression of major ER chaperones, including GRP78 andajp.amjpathol.org - The American Journal of Pathology
UPR and Pathological ReprogrammingGRP94.31,32 Sarqsyan et al33 also provided evidence for
selective induction of UPR pathways in differentiating thy-
roid epithelial cells. They found that rat thyroid cells treated
with a differentiation-inducing hormone cocktail exhibited
activation of the ATF6 and PERK pathways, implying that
physiological levels of the UPR might contribute to the
differentiation process. However, induction of the UPR
may also cause dedifferentiation of thyroid epithelial cells.
Ulianich et al19 reported that induction of ER stress by tuni-
camycin and thapsigargin resulted in substantial down-
regulation of thyroid-speciﬁc genes encoding thyroglobulin,
thyroperoxidase, and thyroid transcription factors in differ-
entiated PC Cl3 thyroid cells. It was associated with i) loss
of transepithelial resistance, ii) suppression of E-cadherin,
and iii) induction of vimentin, a-SMA, and type I collagen
(markers of myoﬁbroblasts). Like in alveolar epithelial cells,
the authors found that theER stresseinduced dedifferentiation
of thyroid cells was prevented by an inhibitor of Src family
kinases or overexpression of a dominant-negative c-Src. These
results suggest that the UPR is involved not only in differen-
tiation of thyroid epithelial cells but also in dedifferentiation of
these cells into myoﬁbroblasts.
Molecular Mechanisms Involved in EMT Triggered by
the UPR
Role of TGF-b
As described, ER stress triggers alveolar epithelial cells and
thyroid epithelial cells toward dedifferentiation into a ﬁbro-
blastic phenotype. Currently, molecular mechanisms under-
lying the UPR-induced EMT are unclear. However, it is
known that TGF-b is a crucial factor that promotes EMT and
myoﬁbroblast formation.2,34 In some cell types, the UPR has
the potential to up-regulate TGF-b signaling.35 The UPRmay
facilitate EMT via activation of TGF-b pathway. Our
previous report suggested that ER stress has the potential to
trigger activation of mitogen-activated protein (MAP)
kinases [extracellular signal-regulated kinase (ERK), c-Jun
N-terminal kinase, and p38 MAP kinase].36 Other reports
also found that TGF-b/Smad signaling is induced by MAP
kinases,37,38 indicating a role for the UPReMAP kin-
aseeTGF-b pathway in the induction of EMT.
Several molecular mechanisms have been proposed for the
induction of EMT by TGF-b, as have been reviewed by
Zavadil and Böttinger.39 During EMT, TGF-b induces acti-
vation of MAP kinase signaling, especially the RaseMEK1/
2eERKpathway,40 which is required for the TGF-beinduced
EMT program.41,42 The MKK3/6ep38 MAP kinaseeATF2
pathway may also be involved in this process.43 TGF-
b induces b-catenin, which mediates production of a-SMA.44
During EMT, TGF-b activates phosphatidylinositol 3-kinase
(PI3K) in a RhoA-dependent manner, and PI3KeAkt
signaling may contribute to down-regulation of ZO-1, cell
migration, and disassembly of intercellular junctions.45
Induction of mesenchymal markers is controlled by some
transcriptional activators. For example, TGF-bemediatedThe American Journal of Pathology - ajp.amjpathol.orginduction of FOXC2 is required for expression of N-cadherin
and vimentin.46,47 SOX4 may also mediate this process.48
On the other hand, it is known that Snail/Slug zinc-ﬁnger
proteins function as repressors of transcription by recog-
nizing E-box elements in their cognate target promoters.
Snail and Slug repress transcription of the E-cadherin gene in
epithelial cells.49,50 TGF-b causes EMT via induction of
Snail and Slug,51e53 and induction of these molecules results
in repression of E-cadherin transcription via proximal E-box
elements in the E-cadherin promoter.54,55 Transcriptional
down-modulation of E-cadherin by TGF-b may also be
mediated by other transcriptional repressors, including Twist,
ZEB1, dEF1, and SIP1.39,56
Role of Src
Another possible target of the UPR to induce EMT is Src.
The Src family tyrosine kinases regulate numerous cellular
events, including tumorigenesis and angiogenesis. In can-
cers, c-Src is frequently activated and facilitates tumor
progression, invasion, and metastasis. Increased c-Src
activity promotes EMT, whereas Src inhibition suppresses
EMT. Impairment of E-cadherinemediated cell adhesion is
important in this process.57 As we described, ER stress
activates the Smad and Src pathways, and combinational
inhibition of Smad2/3 and Src blocked ER stresseinduced
dedifferentiation of alveolar epithelial cells into a ﬁbro-
blastic phenotype.30 Similarly, ER stress-induced dediffer-
entiation (EMT) of thyroid cells was blocked by inhibition
of c-Src.19 Currently, it is unclear how ER stress induces
activation of c-Src. One possibility is involvement of the ER
stresseoxidative stress pathway. Haynes et al58 reported
that activation of the UPR resulted in oxidative stress and
consequent cellular death. Accumulation of reactive oxygen
species (ROS) by the UPR may be caused through ER-
dependent and mitochondria-dependent ROS generation.
Other reports indicated that ROS had the potential to acti-
vate c-Src.59,60 Together with these current ﬁndings, acti-
vation of c-Src may be induced by the UPR through
generation of ROS, leading to EMT.
How does Src induce EMT? Possible mechanisms have
been summarized byNagathihalli andMerchant.57 Src kinases
interfere with E-cadherinemediated cell-to-cell contact by
phosphorylation of E-cadherin/catenin complexes.61,62 Over-
expression of constitutively active c-Src triggers down-
regulation of E-cadherin, leading to cell proliferation and
migration.63 E-cadherin decreases especially at the cell-to-cell
contact when an activemutant of c-Src is overexpressed.64 Src
also binds to E-cadherin, causing disruption of cell-to-cell
interaction.65 Furthermore, Src kinase inhibitors can restore
the function of the E-cadherin signaling in cancer cells,66
indicating a crucial role of Src in the down-regulation and
dysfunction of E-cadherin.
In addition to the down-regulation of E-cadherin, up-
regulation of the mesenchymal markers vimentin and a-
SMA may also be induced by Src. In dedifferentiation of
renal tubular cells, phosphorylation of Src is observed in647
Johno and Kitamuraparallel with expression of vimentin, and the induction of
vimentin is abrogated by treatment with a Src kinase
inhibitor.67 Similarly, expression of a-SMA is suppressed
by the treatment with Src kinase inhibitors.68 Src activates
the RaseRafeMAP kinase pathway,69 and activation of
MAP kinases, especially ERK, results in phosphorylation of
ternary complex factor (TCF) and serum response factor
(SRF).70 TCF induces expression of target genes in a ternary
complex with SRF. A previous report found that over-
expression of SRF induced expression of vimentin.71 SRF
also plays a critical role in the induction of a-SMA.72,73
Possible Link between TGF-b and Src
As described, TGF-b and Src play crucial roles in the
induction of EMT. Interestingly, in experimental glomeru-
lonephritis, inhibition of c-Src may attenuate not only
a-SMA expression but also phosphorylation of Smad1 and
expression of collagen.74 It indicates that c-Src is a mediator
for the TGF-b signaling that triggers EMT. Similar results
were also reported by another group that demonstrated
involvement of SrceERK signaling in TGF-beinduced
collagen expression.75 Alternatively, Src could function
upstream of the TGF-b signaling. Previous reports sug-
gested that Src has the potential to up-regulate expression of
TGF-b1 and TGF-b type II receptor.76,77
Taken together, these data suggest a putative mechanism
underlying the UPR-induced EMT via Src and TGF-b
(Figure 1). However, the concept of EMT contributing to
tissue repair is largely based on in vitro studies, and it is still
unclear whether it can be applicable to human diseases.
There is also ongoing controversy regarding the source of648myoﬁbroblasts in animal models of injury and ﬁbrosis.
Further investigation is required to elucidate these issues
and to clarify exact contribution of TGF-b and Src.Induction of Redifferentiation by the UPR
In the repair of damaged tissues, regenerative processes are
essential to replace lost or damaged cells with new cells arisen
from dedifferentiation and redifferentiation of local cells.78 As
the initial step of regeneration, dedifferentiation is important
because this process allows terminally differentiated cells to
regain the potential for mitogenesis and production of bioac-
tive substances.79 In some situations, the UPRmay contribute
to the dedifferentiation, as described in the former section.
On the other hand, as the ﬁnal step of regeneration, the acti-
vated/dedifferentiated cells must be subsided through redif-
ferentiation. Currently, little is known about mechanisms
responsible for subsidence and redifferentiation of activated/
dedifferentiated cells. Recently, we have provided evidence
that during acute glomerulonephritis, the UPR facilitates
deactivation and redifferentiation of glomerular cells, which
supports reconstruction of normal glomeruli.27
Mesangial Cell Dedifferentiation and Redifferentiation
in Acute Glomerulonephritis
As described, tissue repair requires regenerative processes,
including dedifferentiation and redifferentiation of local
cells. A typical example is dedifferentiation and rediffer-
entiation ofmesangial cells during acutemesangioproliferativeFigure 1 Molecular mechanisms involved in
EMT triggered by the UPR. ER stress and consequent
UPR induce EMT through TGF-b and Src. ER stress
triggers activation of MAP kinases and generation
of ROS, leading to activation of TGF-b signaling and
Src. TGF-bemediated induction of transcriptional
activators (b-catenin, FoxC2, Sox4) is required for
expression of mesenchymal markers (vimentin,
a-SMA, E-cadherin). Induction of transcriptional
repressors (Snail, Slug, Twist, ZEB1, dEF1, SIP1)
contributes to suppression of epithelial markers
(E-cadherin, ZO-1). Activation of PI3KeAkt path-
way may also be involved in this process. On the
other hand, Src impairs expression and function of
E-cadherin and thereby facilitates EMT. Src also
activates MAP kinases, especially ERK, and thereby
up-regulates TCF and SRF, leading to induction of
mesenchymal markers. Cross talk between TGF-
b signaling and Src may also be involved in these
processes.
ajp.amjpathol.org - The American Journal of Pathology
UPR and Pathological Reprogrammingglomerulonephritis. In normal glomeruli, mesangial cells are
quiescent and do not express a-SMA, a known marker for
dedifferentiation. In glomerulonephritis, however, mesangial
cells exhibit active proliferation, migration, expression of a-
SMA, and abundant production of ECM. For example, in
antieThy 1.1 acute glomerulonephritis, Thy 1epositive
mesangial cells are lysed by an antieThy 1 antibody (mesan-
giolysis), and a small population of extraglomerular mesangial
cells migrate into glomeruli and repopulate the mesangial
area.80 During this process, mesangial cells undergo dediffer-
entiation and exhibit active mitogenesis, matrix production,
and expression of a-SMA.81 However, these pathological
changes are transient and subside gradually. In the later phase,
mitogenesis of mesangial cells is terminated, and the number
of mesangial cells decreases through apoptosis. Expansion of
the mesangial matrix is reduced by attenuation of ECM
production, and activated/dedifferentiated mesangial cells
regain a differentiated phenotype in this resolution phase.After
a few months, normal glomeruli are reconstructed.81 At this
stage, mesangial cells do not proliferate actively, do not
produce excessive ECM, and never express a-SMA.79
Induction of the UPR in Acute Glomerulonephritis: Bad
or Good?
Under pathological situations, ER stress is induced in the
kidney and may be involved in the pathogenesis of various
nephropathies, including glomerulonephritis.82,83 Previous
reports have found that theUPR is induced in glomeruli of rats
with passive Heymann nephritis. Preconditioning with ER
stress alleviated proteinuria in this experimental model,84
suggesting pathophysiologic implication of the UPR. Inagi
et al85 also demonstrated that in antieThy 1.1 acute glomer-
ulonephritis, the UPR was induced in nephritic glomeruli,
mainly in mesangial cells. They showed that preconditioning
with moderate ER stress ameliorated pathological manifes-
tations, concluding that ER stress is pathogenic in this disease
model. However, these results cannot exclude a possibility
that ER stress per se directly attenuates glomerulonephritis,
either via suppression of disease progression or via facilitation
of recovery processes. Of note, the UPR may have the anti-
inﬂammatory potential, at least in part, via suppression of
NF-kB, a key regulator for inﬂammatory processes.83 It is still
not well understood whether and how the UPR contributes to
the subsidence and redifferentiation of activated/dediffer-
entiated glomerular cells, especially mesangial cells.
In Vitro Evidence for Redifferentiation of Mesangial
Cells by the UPR
Under serum-stimulated conditions, cultured mesangial cells
exhibit a dedifferentiated phenotype that mimics activated/
dedifferentiated mesangial cells in vivo. That is, they exhibit
active mitogenesis and proliferation, abundant production of
ECM, and intense expression of a-SMA. To examine effects
of the UPR on the dedifferentiated phenotype of mesangialThe American Journal of Pathology - ajp.amjpathol.orgcells, serum-stimulated cells were exposed to subtoxic doses
of ER stress inducers, and mitogenic activity and cellular
death were evaluated. We found that by modest induction of
the UPR, mitogenesis and proliferation of mesangial cells
were attenuated without induction of cellular death.27
Serum-activated mesangial cells also exhibit expression
of a-SMA and production of type IV collagen abundantly.
The UPR might reduce production of these proteins via
transcriptional or translational suppression. To investigate
this issue, activated/dedifferentiated mesangial cells were
treated with ER stress inducers and subjected to analysis.
We found that induction of the UPR down-regulated mRNA
levels of a-SMA and type IV collagen, and it was inversely
correlated with up-regulation of an ER stress marker
CCAAT/enhancer-binding protein-homologous protein
(CHOP). Activity of the a-SMA gene promoter and the type
IV collagen gene promoter was also inhibited by the
induction of the UPR.27
In Vivo Evidence for Redifferentiation of Mesangial
Cells by the UPR
To investigate whether in vivo induction of the UPR also has
the potential to facilitate deactivation and redifferentiation
of mesangial cells, antieThy 1.1 glomerulonephritis was
induced in rats. After 3 days (day 3), the rats were post-
treated with or without the ER stress inducer tunicamycin.
After an additional 4 days (day 7), kidneys were processed
for histopathological analysis and immunohistochemistry.
We found that an antieThy 1.1 antibodyeinduced mesan-
giolysis results in glomerulosclerosis with hypercellularity
and matrix expansion and that this pathological change is
signiﬁcantly attenuated by reinforcement of the UPR by
tunicamycin. Accumulation of type IV collagen and mesan-
gial cell mitogenesis were also reduced by the treatment
with tunicamycin. Consistent with these results, expression
of a-SMA induced in nephritic glomeruli was signiﬁcantly
repressed by the reinforcement of the UPR.27 Of note, in the
glomeruli at day 7, apoptotic cells were hardly detectable
in the tunicamycin-treated group. These results provide
evidence that the UPR has the potential to facilitate deacti-
vation and redifferentiation of mesangial cells not only
in vitro but also in vivo.
Molecular Mechanisms Involved in Redifferentiation of
Mesangial Cells by the UPR
In general, Akt and ERK play crucial roles in mitogenesis
and proliferation of various cell types, including mesangial
cells.86,87 To investigate molecular mechanisms involved in
the antimitogenic effect of the UPR, effects of ER stress
inducers on the activity of Akt and ERK were tested.
Serum-stimulated mesangial cells were treated with ER
stress inducers, and phosphorylation of Akt and ERK was
evaluated. Activated mesangial cells exhibited high levels of
phosphorylated Akt, and it was markedly depressed by the649
Figure 2 A model of mesangial cell dedifferentiation and redifferentiation by the UPR during glomerulonephritis. In mesangioproliferative glomerulo-
nephritis, mesangial cells are activated by local inﬂammatory mediators and exhibit a dedifferentiated phenotype characterized by active proliferation,
abundant ECM production, and abnormal expression of a-SMA. Mitogenesis is caused by phosphorylation of Akt, and production of ECM and a-SMA is mediated
by the TGF-beSmad pathway. Subsequently, the UPR is evoked in mesangial cells by local inﬂammatory milieu and depresses Akt activation and Smad signaling
pathways. These molecular events lead to a shift of activated, dedifferentiated mesangial cells to the normal, redifferentiated phenotype.
Johno and Kitamurainduction of the UPR. In contrast, phosphorylation of ERK
observed in activated cells was unaffected by any of the ER
stress inducers. This result indicated that the Akt pathway is
a selective target for the antimitogenic action of the UPR.
Indeed, inhibition of Akt reduced the number of mesangial
cells due to mitogenic suppression. Furthermore, cells express-
ing constitutively active Akt were resistant to UPR-induced Akt
dephosphorylation and suppression of mitogenesis.27
During the process of mesangioproliferative glomerulo-
nephritis, the TGF-b superfamily plays a key role in theFigure 3 Suppression of growth, ECM synthesis, and cytokine or chemokine
suppression of cyclin D1 through induction of the PERKeeIF2a pathway, culminatin
activation of p53 and consequent induction of p21. The PERKeeIF2a pathway induc
UPR exerts the antimitogenic effect via inhibition of Akt, which is possibly media
chemokine production. The UPR has the potential to cause global translational supp
synthesis and cytokine or chemokine production. The IRE1 pathway causes degradat
ECM components. The UPR, especially the eIF2a pathway, also has the potential
addition to these effects, blockade of NF-kB by the UPR may contribute to attenuat
650expansion of mesangial matrix.88 It may also regulate ex-
pression of a-SMA, as well as type IV collagen, in me-
sangial cells.89,90 The TGF-b superfamily includes TGF-b/
activin and bone morphogenetic protein (BMP). In general,
TGF-b causes phosphorylation of Smad2/3, leading to
activation of its responsive elements, including the CAGA
box. In contrast, Smad1/5/8 are phosphorylated in response
to BMP, leading to activation of the BMP responsive
element. Previous reports found that the stimulatory effect
of TGF-b on ECM synthesis was mediated by Smad391 andproduction by the UPR. A: Growth arrest. ER stress causes translational
g in G0/G1 cell cycle arrest. The PERK pathway also causes accumulation and
es expression of CHOP via ATF4, leading to G1/S arrest. In the later phase, the
ted by the ATF6 pathway. B: Suppression of ECM synthesis and cytokine or
ression via the PERKeeIF2a pathway. It leads to general attenuation of ECM
ion of particular mRNAs (IRE1-dependent mRNA decay), including mRNAs for
to block the Smad signaling, leading to suppression of ECM production. In
ion of cytokine or chemokine production by activated/dedifferentiated cells.
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UPR and Pathological Reprogrammingthat Smad3-knockout mice exhibited limited accumulation
of glomerular ECM under diabetic states.92 Activation of
Smad1 by BMP may also cause mesangial matrix expansion
in diabetic nephropathy.93 We found that TGF-b1 and
BMP4 enhanced expression of a-SMA and type IV collagen
in cultured mesangial cells, which was associated with
phosphorylation of Smads and activation of the CAGA box
and the BMP responsive element. These molecular events
were signiﬁcantly attenuated by induction of the UPR under
both TGF-b/BMP-untreated and -treated conditions. Of note,
total Smad proteins were down-regulated by the UPR, which
was mediated by translational suppression through the
PERKeeukaryotic translation initiation factor 2a (eIF2a)
pathway.27 These results indicate that the UPR interferes
with Smad signaling, leading to down-regulation of a-SMA
and type IV collagen in activated/dedifferentiated mesangial
cells.
To investigate whether in vivo induction of the UPR
suppresses glomerular Akt activity and Smad signaling, we
examined effects of tunicamycin (posttreatment) on antie
Thy 1.1 glomerulonephritis. Consistent with the in vitro
results, administration with tunicamycin reinforced the UPR
and attenuated Akt phosphorylation in glomeruli. Similarly,
the levels of Smad1 and Smad3 were down-regulated by the
treatment with tunicamycin.27 These results suggest that
induction of the UPR attenuates activity of Akt and Smad
signaling in dedifferentiated glomerular cells not only
in vitro but also in vivo.
In the recovery from mesangioproliferative glomerulone-
phritis, activated/dedifferentiated mesangial cells must be
subsided. The aberrant proliferation and matrix production
should be attenuated, and the cells must undergo rediffer-
entiation. The results described above suggest a possibility
that the UPR contributes to this recovery process via dual
suppression of Akt and Smad signaling pathways (Figure 2).
However, this hypothetical model is only based on the
ﬁndings using cultured mesangial cells and experimental
glomerulonephritis. It still remains to be established whether
this concept is applicable to other pathological contexts.
Growth Arrest Caused by the UPR
ER stress is induced under various pathological situations,
including inﬂammation and ﬁbrosis.94 Previous reports
suggested that the UPR has the potential to inhibit cell
proliferation. For example, ER stress causes translational
suppression of cyclin D1 through induction of the
PERKeeIF2a pathway, culminating in G0/G1 cell cycle
arrest.95 Zhang et al96 found that the PERK pathway caused
accumulation and activation of p53 through inhibition of its
ubiquitination and degradation. It causes up-regulation of
p21 and consequent suppression of cyclin-dependent kinase.
The PERKeeIF2a pathway may also contribute to G1/S
arrest via induction of CHOP.97 We also disclosed the
antimitogenic potential of the UPR by inhibiting Akt in
mesangial cells,27 which might be mediated by the ATF6The American Journal of Pathology - ajp.amjpathol.orgpathway.98 Putative mechanisms underlying the induction
of growth arrest by the UPR are summarized in Figure 3A.
Suppression of ECM Synthesis and Cytokine/Chemokine
Production by the UPR
Regarding production of bioactive substances and ECM
components, the UPR may also reverse an activated pheno-
type of cells. First and foremost, the UPR has the potential to
cause global translational suppression via the PERKeeIF2a
pathway.99 It may lead to general attenuation of cytokine/
chemokine production and ECM synthesis. Hollien et al100
reported that ER stress triggers degradation of particular
mRNAs through the IRE1 pathway. mRNAs for type IV
collagen and other ECM components are especially suscep-
tible to this IRE1-dependent mRNA decay, leading to
suppression of ECM production. The UPR, especially the
eIF2a pathway, also has the potential to block the Smad
signaling in some cell types, leading to attenuated production
of ECM.27 These mechanisms may also contribute to deac-
tivation or redifferentiation of activated/dedifferentiated
tissue cells under pathological conditions. In addition,
suppression of NF-kB by the UPR may contribute to atten-
uation of cytokine and chemokine production by activated/
dedifferentiated cells.94,98 Putative mechanisms underlying
suppression of matrix synthesis and cytokine/chemokine
production by the UPR are summarized in Figure 3B.Perspective
In this review, we summarized recent knowledge regarding
hypothetical roles of the UPR in regulating cellular dediffer-
entiation and redifferentiation under pathological states. Acti-
vation or dedifferentiation of resident cells is a common
phenomenon observed in various tissues during inﬂammation
and ﬁbrosis. Usually, activated/dedifferentiated cells prolif-
erate actively and produce abundant bioactive substances (eg,
cytokines, chemokines, and growth factors) and ECM
components, leading to progression of inﬂammation and
ﬁbrosis. Control of the UPR is a possible therapeutic approach
toward suppression of accelerated proliferation and excessive
production of bioactive substances. However, the UPR
possesses not only the light sidebut also thedark side.Although
the UPR is a defense mechanism for cells against external
stress, excessive activation of the UPR causes apoptotic cell
death. The UPR may also depress pathogenic signaling medi-
ated by NF-kB and Akt in the late phase, whereas the UPR
instead activates these pathways transiently in the early
phase.94,101 Similarly, Smad signaling is inhibited by the UPR
in some pathological contexts, whereas it may be activated by
the UPR in other situations.27,35 It is worth noting that the
pathological roles of the UPR are dependent on individual,
different cellular contexts. Further understanding is required
for the biphasic, bidirectional, cell-speciﬁc, and magnitude-
dependent inﬂuences of the UPR on cellular differentiation. It651
Johno and Kitamurais also essential to elucidate selective roles of individual UPR
branches in the pathological in situ reprogramming of somatic
cells for dedifferentiation and redifferentiation.References
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